Neurotech International Limited
NTI.AX·ASX·Healthcare
0.0170+0.0010 (+6.25%)today
At close: Nov 5, 4:10 PM AEDT · May be delayed up to 20 min · AUD
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close0.0160
Open0.0170
Day range0.01600.0170
52-week range0.01000.0210
Off day high0.00%
Off 52-week high−19.05%
Volume152.91K
Avg. volume (3M)4.31M
Market cap27.47M
EPS (TTM)-0.0100
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.02
Shares outstanding1.62B
Short interest—
Earnings dateAug 25, 2025 (est.)
Analyst target—
Profit margin−138.11%
Against its peers
Compare in full ›| NTI.AX | NSB.AX | NEUP | 18H0.F | CNSP | NMRA | |
|---|---|---|---|---|---|---|
| Market cap | 27.47M | 21.04M | 16.13M | 5.11M | 6.34M | 106.35M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | — | -1.2 | — | -11.1 | -0.9 |
| Price/book | — | 1.4 | 0.7 | -1.1 | 0.3 | 2.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −5.88% | −65.52% | −30.37% | −25.00% | −33.30% | −78.06% |
| Today | +6.25% | 0.00% | −0.33% | −23.81% | −4.62% | −0.86% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All NTI.AX news ›Is Neurotech International Closing In on Autism Data (ASX:NTI)?
In late September Neurotech announced that the earliest participant had been dosed in its pivotal study, named Beyond Harmony, which tests the company's lead cannabinoid candidate against placebo in children with autism spectrum disorder.…
From the 4Search news index, newest first.
In the news
1mentions in 30 days
1with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Most coverage from
- kalkinemedia.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.